Barclays maintains Equal-Weight on Avista, raises target to $40
Barclays analyst Michael Lonegan maintained an Equal-Weight rating on Avista and raised the price target to $40 from $39.

*this image is generated using AI for illustrative purposes only.
Barclays analyst Michael Lonegan maintained an Equal-Weight rating on Avista while raising the price target to $40 from $39. The adjustment reflects a revised outlook on the stock's valuation.
Rating and Target Details
The research note confirms the Equal-Weight stance, indicating a neutral performance expectation relative to the broader market. The new price target of $40 represents a modest increase from the previous $39 objective.
| Metric | Value |
|---|---|
| Rating | Equal-Weight |
| Previous Price Target | $39 |
| New Price Target | $40 |
What specific factors drove the revision in Avista's valuation outlook?
How might Avista's upcoming earnings report influence the new price target?
What are the potential risks that could prevent Avista from reaching the $40 target?
























